APYX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Apyx Medical Inc (APYX) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows strong technical indicators, positive analyst sentiment, and growth potential driven by new product launches and geographic expansion. Despite short-term financial losses, the company's revenue growth and strategic opportunities make it a compelling long-term investment.
The technical indicators for APYX are bullish. The MACD is positively expanding above zero, indicating upward momentum. The RSI is neutral at 73.595, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot point (3.753), with resistance levels at 3.951 and 4.074, suggesting potential for further upside.
Positive catalysts include strong analyst upgrades with increased price targets to $6, driven by accelerating growth, cost controls, and expansion opportunities. The upcoming approval of the liposuction handpiece and geographic expansion are expected to boost revenue further.
Negative catalysts include declining net income (-71.93% YoY) and EPS (-75.00% YoY) in the latest quarter. Additionally, the post-market price drop of -3.75% may indicate short-term volatility.
In Q4 2025, Apyx Medical reported a 34.75% YoY increase in revenue to $19.16 million. However, net income dropped to -$1.299 million (-71.93% YoY), and EPS fell to -0.03 (-75.00% YoY). Gross margin slightly declined to 62.61% (-0.67% YoY).
Analysts are bullish on APYX. Craig-Hallum raised the price target to $6, citing strong quarterly performance and growth potential from new product approvals and geographic expansion. BTIG upgraded the stock to Buy from Neutral, highlighting positive momentum from the Ayon launch and demand for skin tightening solutions.
